Dihydrocodeine 30mg

Dihydrocodeine 30mg Tablets – Accord UK Patient Information

Dihydrocodeine 30mg is a prescription opioid pain medicine used for moderate to severe pain when weaker painkillers have not provided enough relief. The live product image shows Accord-branded immediate-release tablets in a box labelled 100 tablets, while the WooCommerce page offers six customer-selectable quantities from 28 to 336 tablets. Dihydrocodeine 30mg should not be treated as an ordinary retail pain product because it can cause drowsiness, constipation, respiratory depression, tolerance, dependence, withdrawal and overdose.

The NHS describes dihydrocodeine as a prescription opioid used for moderate to severe pain, including pain after an operation or serious injury, and sometimes longer-term pain when weaker treatments have not worked. In the UK, dihydrocodeine is a Class B controlled drug. Certain qualifying oral preparations fall within Schedule 5, but the precise legal category depends on the formulation and composition.

What Is Dihydrocodeine 30mg?

Dihydrocodeine 30mg contains dihydrocodeine tartrate, an opioid analgesic that reduces the way pain signals are processed in the brain and central nervous system. It is not the same product as co-dydramol, which combines dihydrocodeine with paracetamol, and it is not the same as prolonged-release DHC Continus tablets.

The displayed Accord pack is labelled as an immediate-release 30mg tablet presentation. Before publication, the pharmacy should confirm the exact product licence, manufacturer, batch number, expiry date, pack size and lawful procurement records. The visible image shows a 100-tablet box, whereas the product page sells quantities beginning at 28 tablets. That difference should be explained through genuine dispensing-pack information rather than left unclear.

What May Dihydrocodeine 30mg Be Used For?

Dihydrocodeine 30mg may be considered for moderate to severe pain when a prescriber decides that an opioid is clinically justified. Examples may include pain after an operation, significant injury or another diagnosed condition that has not responded adequately to weaker pain relief.

It should not automatically be selected for every headache, dental problem, backache or persistent pain condition. Chronic pain often requires investigation and a wider plan that may involve physiotherapy, exercise, psychological support, non-opioid medicines, specialist pain care or treatment of an underlying condition.

Read the website’s guide explaining what dihydrocodeine is for wider educational information.

How Does Dihydrocodeine Work?

Dihydrocodeine 30mg binds to opioid receptors in the brain and spinal cord. This can reduce awareness of pain, but it can also slow breathing, impair alertness and reduce movement through the digestive system.

The medicine may therefore cause constipation, nausea, dizziness and sleepiness. Stronger effects may occur in older adults, medically frail patients, people with breathing disorders and those taking other central nervous system depressants.

Pain relief does not mean the underlying injury or condition has been cured. Dihydrocodeine 30mg should be one part of a clearly defined treatment plan rather than the only response to unexplained or worsening pain.

Why Is a Clinical Pain Assessment Required?

A clinical assessment is necessary before Dihydrocodeine 30mg is considered because opioid suitability depends on the cause of pain, previous treatment, medical history and dependence risk.

The prescriber may review:

• Where the pain is located
• How severe it is
• When it started
• Whether there was an injury or operation
• Treatments already attempted
• Current prescription and pharmacy medicines
• Breathing problems or sleep apnoea
• Liver, kidney and bowel conditions
• Pregnancy or breastfeeding
• Previous opioid treatment
• Alcohol or substance-use history
• Mental-health history
• Signs of tolerance, dependence or medication misuse

Completing an online questionnaire does not guarantee Dihydrocodeine 30mg, a particular quantity or repeat treatment. The clinician may recommend a non-opioid treatment, smaller supply, face-to-face examination, urgent assessment or no medicine.

Short-Term Treatment and Review

Dihydrocodeine 30mg should generally be used at the lowest effective dose for the shortest clinically appropriate period. The MHRA advises prescribers to agree a treatment strategy and an end-of-treatment plan before starting opioids because prolonged use can cause tolerance, dependence and addiction even at therapeutic doses.

The need for treatment should be reviewed rather than renewed automatically. Pain that continues, worsens or changes may require reassessment of the diagnosis.

People who feel that Dihydrocodeine 30mg has stopped working should not increase the amount themselves. Reduced effect can indicate tolerance, worsening disease, opioid-induced hyperalgesia or the need for another treatment approach.

Dihydrocodeine 30mg Compared With Other Pain Options

A stronger medicine is not automatically a better medicine. The correct option depends on the cause of pain, expected duration and individual safety profile.

Common Side Effects

Possible side effects of Dihydrocodeine 30mg include:

• Constipation
• Nausea or vomiting
• Drowsiness
• Dizziness
• Headache
• Dry mouth
• Reduced concentration
• Confusion
• Abdominal discomfort
• Difficulty passing urine
• Low blood pressure
• Blurred vision

Constipation is particularly common with opioids because they slow movement through the bowel. A pharmacist or prescriber may recommend an individual prevention or treatment plan depending on the patient’s health.

Contact the prescribing service if side effects from Dihydrocodeine 30mg are severe, persistent or interfere with normal daily activities.

Serious Side Effects and Overdose

Urgent medical assistance is required if someone taking Dihydrocodeine 30mg develops:

• Slow, shallow or difficult breathing
• Extreme drowsiness
• Inability to wake
• Blue or grey lips
• Collapse
• Loss of consciousness
• Pinpoint pupils with poor responsiveness
• Severe confusion
• A seizure
• A serious allergic reaction
• Suspected overdose

Opioid overdose can suppress breathing and cause coma or death. Severe sedation must not be mistaken for normal sleep. Emergency services should be contacted when breathing is abnormal or the person cannot be awakened.

Alcohol and Dihydrocodeine

Alcohol should be avoided while using Dihydrocodeine 30mg. Both substances depress the central nervous system and can increase sleepiness, impaired judgement, falls, low blood pressure, breathing suppression and overdose risk.

A person should not use alcohol to strengthen pain relief or help them sleep. The combination can cause dangerous effects even when each substance is taken separately in an amount the person has previously tolerated.

Benzodiazepines, Sleeping Tablets and Other Sedatives

Combining Dihydrocodeine 30mg with benzodiazepines or benzodiazepine-like sleeping medicines can produce additive respiratory depression. The MHRA warns that opioid and benzodiazepine combinations increase the risk of profound sedation, coma and death.

Important examples include:

• Diazepam
• Clonazepam
• Alprazolam
• Lorazepam
• Temazepam
• Zopiclone
• Zolpidem
• Pregabalin
• Gabapentin
• Sedating antihistamines
• Certain antidepressants and antipsychotics

The prescriber must receive a complete list of medicines and substances, including products purchased online or used only occasionally. The NHS specifically advises patients to report sleeping tablets, tranquillisers, mental-health medicines and sedating antihistamines before using dihydrocodeine.

Combining Dihydrocodeine With Other Painkillers

Dihydrocodeine 30mg may sometimes form part of a plan that also uses a non-opioid medicine, but ingredient duplication must be avoided.

Co-dydramol already contains dihydrocodeine and paracetamol. Taking separate Dihydrocodeine 30mg with co-dydramol can produce excessive opioid exposure. Taking additional paracetamol alongside combination products may also lead to accidental overdose.

Do not combine dihydrocodeine with codeine, tramadol, tapentadol, morphine, oxycodone or another opioid unless a qualified clinician has specifically reviewed and authorised the combination.

Read whether dihydrocodeine is stronger than codeine for a general comparison.

Dependence, Tolerance and Opioid Use Disorder

Repeated Dihydrocodeine 30mg use can cause tolerance and physical dependence. Tolerance means that the original effect becomes weaker, while dependence means the body has adapted and may react when treatment is reduced or stopped.

Possible signs of opioid use disorder include:

• Craving the medicine
• Taking more than prescribed
• Using it for sleep, relaxation or emotional relief
• Repeated early supply requests
• Continuing despite harm
• Visiting multiple providers
• Feeling unable to function without it
• Combining it with alcohol or sedatives

The MHRA states that prolonged opioid use can cause dependence and addiction even at therapeutic doses. Patients with a current or previous substance-use disorder or certain mental-health conditions may need additional monitoring.

Withdrawal Symptoms

Stopping regular Dihydrocodeine 30mg suddenly can cause withdrawal symptoms such as:

• Restlessness
• Anxiety or irritability
• Sweating and chills
• Runny nose and watery eyes
• Yawning
• Muscle aches
• Difficulty sleeping
• Abdominal cramps
• Nausea, vomiting or diarrhoea
• Tremor
• Palpitations
• Increased blood pressure

A person who has taken Dihydrocodeine 30mg regularly should seek medical advice before reducing or stopping it. A gradual taper may be required and can take different lengths of time depending on the treatment history.

Who May Not Be Suitable?

Dihydrocodeine 30mg may be unsuitable or require specialist caution for people with:

• Acute respiratory depression
• Severe breathing disease
• An acute asthma attack
• Sleep apnoea
• Head injury or raised intracranial pressure
• Severe liver impairment
• Certain bowel-obstruction conditions
• Acute alcohol intoxication
• Previous opioid allergy
• A history of opioid misuse
• Significant frailty
• Pregnancy or breastfeeding
• Concurrent sedative treatment

The exact contraindications depend on the authorised product information, so the patient leaflet for the medicine actually supplied must be checked.

Pregnancy and Breastfeeding

Dihydrocodeine 30mg during pregnancy requires individual medical review. Opioids cross the placenta, and repeated use may cause dependence and withdrawal in the newborn. Use around delivery may also suppress the baby’s breathing.

Tell the prescriber if you are pregnant, planning pregnancy or breastfeeding. Do not begin, continue or stop regular opioid treatment without professional advice.

Driving and Daily Safety

This opioid can cause drowsiness, dizziness, blurred vision, confusion and slower reactions. Do not drive, cycle, operate machinery or perform hazardous work when affected.

A prescription does not make it safe or lawful to drive while impaired. Alcohol and sedating medicines increase the risk further.

Secure Storage and Disposal

Store the medicine:

• In the original labelled packaging
• In a locked or secure location
• Out of sight and reach of children
• Away from visitors and household members
• Away from anyone with a history of opioid misuse

Never share, sell or give the medicine to another person. Return unwanted or expired tablets to a pharmacy rather than placing them in household waste or wastewater.

Product-Page Corrections Required

The current page should be corrected before publication:

1. Replace the “Buy Dihydrocodeine Online UK” headline with a neutral patient-information heading.
2. Remove fixed adult and child dosage instructions.
3. Remove the external competitor link and satisfaction guarantee.
4. Remove sleeping-pill tags because it is an opioid pain medicine.
5. Remove unrelated erectile-dysfunction products from the “Same Brand” section.
6. Remove zopiclone and other sedatives from related products.
7. Explain why the image shows 100 tablets while variations begin at 28.
8. Verify the exact Accord product licence and manufacturer.
9. Replace direct purchase-first wording with a confidential pain-assessment CTA.
10. Remove worldwide-shipping and generic medicine-return claims unless legally verified.

Prescription-only medicines cannot be advertised directly to the UK general public, so the page should explain the clinical service rather than encourage unrestricted purchase or bulk selection.

How a Responsible Online Assessment Should Work

Step 1: Complete a Confidential Pain Assessment

Provide accurate information about the pain, diagnosis, treatment history, current medicines, alcohol use and previous opioid exposure.

Step 2: Receive an Independent Prescriber Review

A qualified clinician decides whether the requested opioid or another treatment is medically appropriate.

Step 3: Receive the Treatment Decision

The clinician may approve a suitable short course, recommend a non-opioid option, ask for more information, refer for face-to-face care or decline treatment.

Step 4: Complete Pharmacy Checks

The pharmacy verifies the prescription, exact Accord product, interactions, pack quantity, batch, stock and lawful supply route.

Step 5: Dispatch Only After Approval

Dispatch should begin only after a valid prescription and all pharmacy checks are complete. Review the delivery information and frequently asked questions before submitting an assessment.

Frequently Asked Questions

What is this medicine used for?

It may be prescribed for moderate to severe pain when weaker painkillers have not provided enough relief.

Is this medicine available without a prescription?

No. It is a prescription-only opioid medicine and requires a valid prescription and lawful pharmacy process.

Is dihydrocodeine controlled in the UK?

Yes. Dihydrocodeine is a Class B controlled drug. Certain qualifying oral preparations can fall within Schedule 5.

Is this opioid a sleeping tablet?

No. It may cause drowsiness, but it is an opioid pain medicine and should not be used merely to induce sleep.

Can this medicine cause addiction?

Yes. Repeated or prolonged use can cause tolerance, dependence, addiction and withdrawal, including at therapeutic doses.

Can alcohol be taken with dihydrocodeine?

No. Alcohol increases sedation, breathing suppression, unconsciousness and overdose risk.

Can dihydrocodeine be combined with zopiclone or diazepam?

Only after specific clinical review. Combining opioids with benzodiazepines or sleeping medicines can cause potentially fatal respiratory depression.

Can this medicine be taken with co-dydramol?

Co-dydramol already contains dihydrocodeine. Additional dihydrocodeine should not be taken unless specifically authorised by a qualified healthcare professional.

Can regular dihydrocodeine treatment be stopped suddenly?

Regular treatment should not normally be stopped suddenly because withdrawal symptoms may occur. A gradual reduction may be required.

Is a prescription guaranteed?

No. A prescriber may recommend another treatment, a smaller quantity, further assessment or no opioid medicine.

Final Thoughts

This prescription opioid may help selected patients with moderate to severe pain when weaker medicines have not worked adequately. Its possible benefit must be balanced against constipation, sedation, breathing suppression, tolerance, dependence, withdrawal and overdose.

The live page should remove fixed dosage instructions, sleeping-pill tags, the external competitor link, unrestricted bulk-selection language and unrelated product recommendations. It should also reconcile the 100-tablet Accord image with the six smaller purchase variations and verify the precise product licence.

The medicine should be supplied only after individual clinical assessment, a valid prescription and pharmacy checks. Patients should use it exactly as prescribed, avoid alcohol and unapproved sedatives, and seek urgent help for slow breathing, collapse or difficulty waking.